Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
carnitine O-acetyltransferase | 0.656 | 0.577 | 9.5E-12 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2020 | 2020 | ||||||||
|
carnitine O-acetyltransferase | 0.656 | 0.577 | 9.5E-12 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2020 | 2020 | ||||||||
|
carnitine O-acetyltransferase | 0.656 | 0.577 | 9.5E-12 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2020 | 2020 | ||||||||
|
carnitine O-acetyltransferase | 0.656 | 0.577 | 9.5E-12 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2020 | 2020 | ||||||||
|
carnitine O-acetyltransferase | 0.656 | 0.577 | 9.5E-12 |
|
phenotype | 0.110 | None | 1.000 | 1 | 2 | 2020 | 2020 | ||||||||
|
carnitine O-acetyltransferase | 0.656 | 0.577 | 9.5E-12 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2020 | 2020 | ||||||||
|
carnitine O-acetyltransferase | 0.656 | 0.577 | 9.5E-12 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2020 | 2020 | ||||||||
|
abnormal spindle microtubule assembly | 0.526 | 0.769 | 3.4E-49 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2020 | 2020 | ||||||||
|
abnormal spindle microtubule assembly | 0.526 | 0.769 | 3.4E-49 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2020 | 2020 | ||||||||
|
SET binding protein 1 | 0.503 | 0.808 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2020 | 2020 | ||||||||
|
SET binding protein 1 | 0.503 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2020 | 2020 | ||||||||
|
1,4-alpha-glucan branching enzyme 1 | 0.612 | 0.654 | 1.1E-12 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2020 | 2020 | ||||||||
|
1,4-alpha-glucan branching enzyme 1 | 0.612 | 0.654 | 1.1E-12 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2020 | 2020 | ||||||||
|
gliomedin | 0.769 | 0.346 | 2.6E-13 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2020 | 2020 | ||||||||
|
gliomedin | 0.769 | 0.346 | 2.6E-13 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2020 | 2020 | ||||||||
|
tubulin beta 8 class VIII | 1.000 | 1.8E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2020 | 2020 | |||||||||
|
ATPase Na+/K+ transporting subunit alpha 2 | 0.597 | 0.615 | 1.8E-04 |
|
disease | 0.400 | None | 1.000 | 1 | 2 | 2020 | 2020 | ||||||||
|
ATPase Na+/K+ transporting subunit alpha 2 | 0.597 | 0.615 | 1.8E-04 |
|
disease | 0.410 | None | 1.000 | 1 | 2 | 2020 | 2020 | ||||||||
|
ATPase Na+/K+ transporting subunit alpha 2 | 0.597 | 0.615 | 1.8E-04 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2020 | 2020 | ||||||||
|
receptor tyrosine kinase like orphan receptor 2 | 0.498 | 0.731 | 1.2E-04 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2020 | 2020 | ||||||||
|
receptor tyrosine kinase like orphan receptor 2 | 0.498 | 0.731 | 1.2E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2020 | 2020 | ||||||||
|
receptor associated protein of the synapse | 0.593 | 0.731 | 1.5E-03 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2020 | 2020 | ||||||||
|
receptor associated protein of the synapse | 0.593 | 0.731 | 1.5E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2020 | 2020 | ||||||||
|
ryanodine receptor 1 | 0.489 | 0.808 | 1.6E-29 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2020 | 2020 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2020 | 2020 |